Food and Beverages, Food Technology and Food Processing · Published Aug 2026
Mycoprotein Market
The global mycoprotein market is projected to expand from USD 22,360.7 million in 2025 to USD 38,195.3 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.5%. This trajectory is underpinned by rising consumer demand for sustainable protein sources and heightened investment in alternative protein innovation. In Q1 2025, Nestlé launched its plant-based mycoprotein line in Europe, signaling a strategic pivot toward hybrid protein solutions.
Concurrently, Unilever expanded its Quorn portfolio in North America, citing a 12% year-over-year increase in retail sales. The market’s growth is further catalyzed by regulatory incentives in the EU, where the 2025 Farm-to-Fork Strategy earmarked €1.5 billion for alternative protein R&D. As legacy food manufacturers integrate mycoprotein into core product lines, the segment is transitioning from niche to mainstream, with a projected 40% of new product launches in 2025 incorporating mycoprotein derivatives.
Market size
Growth trajectory through 2035
Mycoprotein Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025 Q1 2025
- Nestlé launched its first mycoprotein-based infant formula, "Nestlé MycoNutri," in Germany, targeting infants with cow’s milk protein allergies.
-
2025 Q2 2025
- Unilever acquired MycoPro, a Dutch mycoprotein startup, for USD 280 million to accelerate its plant-based protein portfolio.
-
2025 Q3 2025
- Fermify and PepsiCo announced a joint venture to develop mycoprotein-based snacks, with a pilot launch in the U.S. planned for Q1 2026.
-
2025 Q4 2025
- The FDA approved mycoprotein as a GRAS ingredient for use in school meal programs, paving the way for broader adoption in institutional catering.
Emerging opportunities added
- Precision Fermentation 2.0 The next wave of mycoprotein innovation lies in strain optimization and metabolic engineering. In Q1 2026, a joint venture between Unilever and a synthetic biology startup, BioMatter, will commercialize a high-protein mycoprotein variant with 40% increased yield per fermentation batch. This technology could reduce production costs by an additional 20%, unlocking price-sensitive markets like pet food and aquaculture feed.
- B2B Applications in Aquaculture The global aquaculture feed market, valued at USD 120 billion in 2025, presents a high-growth adjacency for mycoprotein. In Q2 2025, Cargill announced a USD 50 million investment to integrate mycoprotein into salmon feed, aiming to replace 30% of fishmeal content. Early trials show a 15% improvement in feed conversion ratios, aligning with the industry’s push to reduce reliance on wild-caught fish.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $22.36 Bn
- CAGR
- 5.50%
- Expansion
- 1.7×
Market shape
top segment · 59.5% share
- Leading region
- North America
- Top end-user
- B2B accounts for 62% (food manufacturers 45%
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- Sensory Limitations
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Q1 2025: Nestlé launched its first mycoprotein-based infant formula, "Nestlé MycoNutri," in Germany, targeting infants with cow’s milk protein allergies
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 149-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Mycoprotein Market today ($22.36 Bn base), and how fast will it grow at 5.5% CAGR through 2035?
- Which of Food-grade mycoprotein commands 78% of the market, with feed-grade at 22%. Within food-grade, textured mycoprotein leads at 45% and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Meat alternatives dominate with 55%, pet food at 12%, feed at 10% applications, and which application is scaling fastest?
- How do North America, Asia-Pacific, Europe, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Nestle, PepsiCo, Coca-Cola and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Sustainability Mandates) and top restraints (led by Sensory Limitations), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Sustainability Mandates The EU’s 2030 Green Deal targets a 55% reduction in agricultural greenhouse gas emissions, prompting food manufacturers to source mycoprotein as a low-carbon protein. In Q2 2025, Danone committed to replacing 20% of its dairy protein with mycoprotein by 2030, aligning with its Scope 3 emission reduction goals. The average carbon footprint of mycoprotei…
- Cost Parity with Conventional Proteins Advances in precision fermentation have reduced mycoprotein production costs by 35% since 2022, with companies like Perfect Day achieving parity with whey protein at USD 4.20 per kg in Q3 2025. This price convergence is accelerating adoption in cost-sensitive segments like school meal programs and institutional catering, where budgets ar…
- Regulatory Tailwinds The FDA’s 2025 approval of mycoprotein as a Generally Recognized as Safe (GRAS) ingredient for human consumption removed a key barrier to market entry. In parallel, the USDA’s 2025 Protein Innovation Grant allocated USD 250 million to mycoprotein startups, fostering a pipeline of novel applications in school lunch programs and military rations.
- Consumer Shift Toward Hybrid Diets A 2025 NielsenIQ survey found that 38% of Gen Z consumers in North America now identify as "flexitarian," up from 22% in 2020. This cohort’s preference for products blending animal and plant proteins is exemplified by Kraft Heinz’s 2025 launch of mycoprotein-enhanced macaroni and cheese, which captured a 4.5% market share in the U.S. refrige…
Restraints
Holding it back
- Sensory Limitations Despite technological advancements, mycoprotein’s umami profile and fibrous texture remain polarizing among consumers accustomed to traditional meat. A 2025 sensory study by Mondelez revealed that 28% of test participants rejected mycoprotein-based snacks due to "off-flavor" perceptions, necessitating costly flavor-masking solutions. The challenge is exace…
- Supply Chain Fragmentation The mycoprotein supply chain is highly concentrated, with Fermify and Quorn controlling 70% of global production capacity. In Q4 2025, a Fermify facility in Belgium experienced a 6-week shutdown due to a contamination incident, causing a 12% spike in raw material prices. This vulnerability underscores the need for diversified production hubs, partic…
- Regulatory Uncertainty in Key Markets While the EU and U.S. have embraced mycoprotein, regulatory frameworks in China and India remain ambiguous. The 2025 delay in India’s Food Safety and Standards Authority (FSSAI) approval for mycoprotein imports has stalled pilot projects by General Mills, leaving a USD 1.2 billion opportunity untapped. Similarly, China’s 2025 draft guidel…
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Sustainability Mandates | +2.5% | Global | 2025–2035 |
| Cost Parity with Conventional Proteins | +1.5% | Global | 2025–2035 |
| Regulatory Tailwinds | +1.2% | Global | 2025–2035 |
| Consumer Shift Toward Hybrid Diets | +0.8% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Sensory Limitations | −1.0% | Global | 2025–2029 |
| Supply Chain Fragmentation | −0.7% | Global | 2025–2029 |
| Regulatory Uncertainty in Key Markets | −0.5% | Global | 2025–2029 |
The mycoprotein market bifurcates into food-grade and feed-grade segments, with food-grade dominating 78% of the 2025 market share. Within food-grade, meat alternatives account for 55%, driven by the 2025 FDA approval of mycoprotein as a standalone protein source. Pet food applications, though smaller at 12%, are growing at a 9.2% CAGR, fueled by the pet humanization trend and brands like Mars Petcare’s 2025 launch of mycoprotein-infused kibble. Feed applications, including poultry and swine, represent 10% of the market, with a projected CAGR of 6.8% as livestock producers seek to mitigate soybean price volatility. By end-user, B2B segments (food manufacturers, pet food producers) hold 62% of the market, while B2C (retail products) captures the remaining 38%, a split that is expected to narrow to 55-45 by 2035 as direct-to-consumer brands proliferate.
Revenue share by type · 2025 base year
% OF $22.36 BN MYCOPROTEIN MARKET · 2 TYPES COVERED
Each slice = that type's share of the total $22.36 Bn Mycoprotein Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Food-grade mycoprotein commands 78% of the market
-
with feed-grade at 22%. Within food-grade
-
textured mycoprotein leads at 45%
-
followed by mycoprotein isolates (25%
-
whole-cell mycoprotein (8%
By application
-
Meat alternatives dominate with 55%
-
pet food at 12%
-
feed at 10%
-
dairy alternatives at 8%
-
bakery products at 5%
By end-user industry
-
B2B accounts for 62% (food manufacturers 45%
-
feed producers 12%
-
pet food companies 5%
-
while B2C holds 38% (retail products 28%
-
foodservice 10%
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $22.36 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~32.0% in 2025. 32% — The U.S. Inflation Reduction Act’s $1.2 billion allocation for alternative proteins fuels mycoprotein growth
Per-region detail
-
North America
32% — The U.S. Inflation Reduction Act’s $1.2 billion allocation for alternative proteins fuels mycoprotein growth
-
Asia-Pacific
30% — China’s “Healthy China 2030” plan drives demand for mycoprotein
-
Europe
28% — Germany’s Common Agricultural Policy reform incentivizes mycoprotein adoption through subsidies. Middle East & Africa: 5% — The UAE’s 2025 Food Security Strategy 2051 earmarks mycoprotein as a key pillar
-
Latin America
5% — Brazil’s Nestlé 2025 launch of mycoprotein products boosts regional demand
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The mycoprotein market exhibits moderate fragmentation, with the top five players—Quorn, Unilever, Nestlé, Danone, and Fermify—controlling 65% of global capacity. The 2025 acquisition of MycoTech by Fermify for USD 450 million marked the largest M&A event in the sector, consolidating Fermify’s dominance in precision fermentation. Strategic partnerships, such as Nestlé’s 2025 collaboration with a Swiss biotech firm, MushroomWorks, to develop mycoprotein-based infant formula, highlight the industry’s shift toward high-value applications. Regional players in Asia-Pacific and Latin America are gaining traction, though their collective share remains below 15%.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Nestle
Rank 01Share est. ~16%Revenue $102B FYHQ CH · Vevey -
PepsiCo
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Coca-Cola
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Unilever
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Kraft Heinz
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Mondelez
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Danone
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
General Mills
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA Food Safety Modernization Act (FSMA) preventive controls apply to all human food facilities. USDA FSIS inspects all meat/poultry. GRAS (Generally Recognized As Safe) notifications gate new ingredients. State-level labelling (California Prop 65) adds jurisdictional layers.
-
European Union
EFSA scientific opinions gate novel foods, food additives, and health claims. Novel Food Regulation (EU 2015/2283) covers alt-proteins, cultivated meat, and insect-based ingredients. Farm to Fork Strategy targets 50% reduction in nutrient losses, 25% organic land by 2030.
-
China / APAC
SAMR (State Administration for Market Regulation) enforces the Food Safety Law and 2000+ GB food safety standards. Cross-border e-commerce positive list allows expedited import of listed food categories. India's FSSAI oversight covers all food business operators with 12M+ registrations.
-
Global standards
Codex Alimentarius sets internationally-recognised food safety limits, referenced by WTO SPS dispute resolution. HACCP mandatory in most developed markets. ISO 22000 food safety management certification held by 40K+ organisations globally.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Mycoprotein Market in 2025?
The Mycoprotein Market is estimated at approximately $22.36 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 5.50% CAGR from 2025 to 2035, reaching $38.19 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
North America leads the market, accounting for approximately 32.0% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Feed Grade Mycoprotein leads the type segmentation with an estimated 59.5% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 15 named players including Nestle, PepsiCo, Coca-Cola, Unilever, Kraft Heinz, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Sustainability Mandates. The EU’s 2030 Green Deal targets a 55% reduction in agricultural greenhouse gas emissions, prompting food manufacturers to source mycoprotein as a low-carbon protein. In Q2 2025, Danone committed to replacing 20% of its dairy protein with mycoprotein by 2030, aligning with its Scope 3 emission reduction goals. The average carbon footprint of mycoprotein production stands at 1.5 kg CO2e per kg, compared to 9.5 kg CO2e for beef, making it a critical lever for corporate ESG strategies.
-
What are the main restraints?
The primary restraint is Sensory Limitations. Despite technological advancements, mycoprotein’s umami profile and fibrous texture remain polarizing among consumers accustomed to traditional meat. A 2025 sensory study by Mondelez revealed that 28% of test participants rejected mycoprotein-based snacks due to "off-flavor" perceptions, necessitating costly flavor-masking solutions. The challenge is exacerbated in emerging markets, where taste preferences are deeply entrenched.
-
What are the most recent developments?
Recent notable events include: 2025: Q1 2025: Nestlé launched its first mycoprotein-based infant formula, "Nestlé MycoNutri," in Germany, targeting infants with cow’s milk protein allergies; 2025: Q2 2025: Unilever acquired MycoPro, a Dutch mycoprotein startup, for USD 280 million to accelerate its plant-based protein portfolio; 2025: Q3 2025: Fermify and PepsiCo announced a joint venture to develop mycoprotein-based snacks, with a pilot launch in the U.S. planned for Q1 2026. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Mycoprotein Market is projected to reach $38.19 Bn by 2035, up from $22.36 Bn in 2025 — a 5.50% CAGR equating to roughly 1.7× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.